Michael Wang, MD

Articles by Michael Wang, MD

Michael Wang, MD, Discusses the SYMPATICO Study on Ibrutinib Plus Venetoclax in MCL

Michael Wang, MDMantle Cell Lymphoma | December 22, 2023

Progression-free survival was significantly prolonged with the combination compared with a placebo.